Secondary endpoint profile is strongly supportive for the positive outcome of the pivotal Phase III study with PQ Grass 27600 SU

Secondary endpoint profile is strongly supportive for the positive outcome of the pivotal Phase III study with PQ Grass 27600 SU

S. Zielen, J. A. Bernstein, U. Berger, M. Berger, R. Mösges, MH Shamji, LM DuBuske, M. Seybold, O. Armfield, K. Lis, K. Oluwayi, X. Pedragosa, M.F. Kramer, M.A. Skinner, P.J. de Kam; Session L-TPS09 - Allergen immunotherapy 7; EAACI 2024 Congress